Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphoma, with different clinical manifestation and prognosis. The International Prognostic Index (IPI), an index designed during the prerituximab era for aggressive lymphoma, showed variable values in the prediction of patient clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Qing, Shen, Rong, Wang, Chao-Fu, Fan, Xing, Qian, Ying, Ou-Yang, Bin-Shen, Zhao, Yan, Leboeuf, Christophe, Janin, Anne, Cheng, Shu, Wang, Li, Zhao, Wei-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646333/
https://www.ncbi.nlm.nih.gov/pubmed/29109622
http://dx.doi.org/10.1155/2017/7960907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646333/
https://www.ncbi.nlm.nih.gov/pubmed/29109622
http://dx.doi.org/10.1155/2017/7960907

Ejemplares similares